PlainPharmaWatch

CMS Open Payments · Program Year 2024

Dutch Ophthalmic Research Center (International) B.V.

Dutch Ophthalmic Research Center (International) B.V. reported $12,128.07 across General Payments, Research, and Ownership to 29 physicians and teaching hospitals across 29 transactions.

$12.1K Below-median payer
All-tracks total
29 Below-median volume
Transactions
29 Below-median reach
Recipients
+$7.1K
General Payments vs PY2023

Dutch Ophthalmic Research Center (International) B.V. reported $12,128.07 across all CMS Open Payments tracks (General + Research + Ownership) to 29 physicians and teaching hospitals in Program Year 2024 - ranking #1614 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $12,128.07, averaging $418.21 per recipient.

Dutch Ophthalmic Research Center (International) B.V.'s payment reach score

Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.

Overall reach score

F

17/100

Total payments

F

10/100

Transaction volume

F

10/100

Physician reach

F

10/100

Payment type diversity

F

37/100

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

CMS Sunshine Act warrant

Manufacturer dutch-ophthalmic-research-center-international-b-v Dutch Ophthalmic Research Center (International) B.V.

$12.1K · #1614/1,925 · 0.0% industry · PY2024

  • TOT $12.1K
  • RANK #1614
  • SHARE 0.0%
  • TXN 29
  • RCP 29
  • CAT 3
  • GEN $12.1K
  • ΔGEN +$7.1K
  • TOP1 78.6%
  • PY 2024

Nearest volume peer: Smaio USA Corporation ($12.2K)

Validus Pharmaceuticals LLC$12.3KSmaio USA Corporation$12.2KDutch Ophthalmic Research Ce…$12.1KAstellas Pharma Europe BV$12.0KBlue Surgical Llc$12.0K
All-tracks payment totals near Dutch Ophthalmic Research Center (International) B.V. (CMS Open Payments PY2024)

Dutch Ophthalmic Research Center (International) B.V. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Dutch Ophthalmic Research Center (International) B.V.'s CMS-reported General Payments increased by $7.1K (+140.3%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: DUTCH OPHTHALMIC RESEARCH CENTER (INTERNATIONAL) B.V.PY2023: DUTCH OPHTHALMIC RESEARCH CENTER (INTERNATIONAL) B.V.PY2024: Dutch Ophthalmic Research Center (International) B.V.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$5.0KPY2024$12.1K
PY2023
$5,046.21
PY2024
$12,128.07

What the Data Shows for Dutch Ophthalmic Research Center (International) B.V.

Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Dutch Ophthalmic Research Center (International) B.V. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.

The 3-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Travel and Lodging" at $8.3K, accounting for 68.2% of this company's General Payments and 16 transactions.

General Payment Breakdown by Type

Across 3 types of general payments, Dutch Ophthalmic Research Center (International) B.V.'s largest category was "Travel and Lodging" at $8.3K - 68.2% of General Payments.

How Dutch Ophthalmic Research Center (International) B.V. divides its payments

Ranked by total dollars reported per category

1. Travel and Lodging$8.3K2. Consulting Fee$3.4K3. Food and Beverage$484.25
Payment Type Amount Transactions
Travel and Lodging $8.3K 16
Consulting Fee $3.4K 1
Food and Beverage $484.25 12

Recipient Concentration in General Payments

The five largest recipient relationships account for $12,128.07 (100.0%) of $12,128.07 in this company's General Payments records across 4 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Dutch Ophthalmic Research Center (International) B.V.

The five named recipients with the highest reported General Payments from this company

Christopher D Riemann$9.5KFarrell Clifton Tyson$1.3KDilraj S Grewal$1.2KCourtney M Crawford$21.21
  1. 1

    Christopher D Riemann

    $9,535.79 across 7 reported transactions

  2. 2

    Farrell Clifton Tyson

    $1,339.85 across 5 reported transactions

  3. 3

    Dilraj S Grewal

    $1,231.22 across 16 reported transactions

  4. 4

    Courtney M Crawford

    $21.21 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Spend vs. Concentration

Dutch Ophthalmic Research Center (International) B.V. ranks #1614 of 1,925 by total payments (bottom 16% by spend) but is notably more concentrated than that alone would suggest -- #249 of 1,838 by HHI (top 14% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.

00.30.50.81.16287.36351.96416.56481.16545.8Total payments ($M)Concentration (HHI, 0-10,000)
Dutch Ophthalmic Research Center (International) B.V. (highlighted) among its 12 nearest HHI-concentration neighbors, Program Year 2024. Dashed lines mark this neighborhood's median payment total and median HHI. Hover a point for the company name. Source: company_concentration (CMS Open Payments general-payment recipients).
View all 12 companies in this HHI neighborhood as a list

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Dutch Ophthalmic Research Center (International) B.V.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Dutch Ophthalmic Research Center (International) B.V..

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Dutch Ophthalmic Research Center (International) B.V..

Showing 6 of 1,924 companies with CMS-reported payment data.

Put this to use

Dutch Ophthalmic Research Center (International) B.V. ranks #1614 of 1,925 by all-tracks total payments, led by "Travel and Lodging".

Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

View saved (companies)
Download Dutch Ophthalmic Research Center (International) B.V.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.